Twist Bioscience
Twist Bioscience (NASDAQ: TWST) is a publicly traded DNA Synthesis & Biofoundries company founded in 2013 and based in South San Francisco, United States.
Twist Bioscience was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck, and pioneered a method of manufacturing synthetic DNA by writing it on a silicon chip, miniaturizing the reaction to boost throughput and lower cost. It sells synthetic genes, oligonucleotide pools, next-generation sequencing (NGS) preparation tools, and antibody libraries for drug discovery, and pursues longer-term opportunities in DNA-based digital data storage. The company opened a highly automated 'Factory of the Future' in Wilsonville, Oregon, which began shipping commercial product in early 2023. Twist went public on NASDAQ in 2018 under the ticker TWST.
The only commercial-scale DNA manufacturer running a silicon-chip platform, making it the default high-throughput supplier for synthetic biology, diagnostics, and DNA data storage R&D.
twistbioscience.com ↗·DNA Synthesis & Biofoundries·
United States·public · NASDAQ: TWST 
